These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 33616001)

  • 1. Identification of critical chemical modifications by size exclusion chromatography of stressed antibody-target complexes with competitive binding.
    Shi RL; Xiao G; Dillon TM; McAuley A; Ricci MS; Bondarenko PV
    MAbs; 2021; 13(1):1887612. PubMed ID: 33616001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of critical chemical modifications and paratope mapping by size exclusion chromatography of stressed antibody-target complexes.
    Bondarenko P; Nichols AC; Xiao G; Shi RL; Chan PK; Dillon TM; Garces F; Semin DJ; Ricci MS
    MAbs; 2021; 13(1):1887629. PubMed ID: 33615991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Trastuzumab-HER2 Complex Formation on Stress-Induced Modifications in the CDRs of Trastuzumab.
    Spanov B; Aboagye V; Olaleye O; Govorukhina N; van de Merbel NC; Bischoff R
    Front Chem; 2021; 9():794247. PubMed ID: 35047480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A competitive binding-mass spectrometry strategy for high-throughput evaluation of potential critical quality attributes of therapeutic monoclonal antibodies.
    Zhang Z; Yan Y; Wang S; Li N
    MAbs; 2022; 14(1):2133674. PubMed ID: 36224723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of Bispecific Antibody Production in Cell Cultures by Unique Mixed Mode Size Exclusion Chromatography.
    Jiang H; Xu W; Liu R; Gupta B; Kilgore B; Du Z; Yang X
    Anal Chem; 2020 Jul; 92(13):9312-9321. PubMed ID: 32497423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid identification of an antibody DNA construct rearrangement sequence variant by mass spectrometry.
    Scott RA; Rogers R; Balland A; Brady LJ
    MAbs; 2014; 6(6):1453-63. PubMed ID: 25484040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydrogen deuterium exchange mass spectrometry identifies the dominant paratope in CD20 antigen binding to the NCD1.2 monoclonal antibody.
    Uhrik L; Hernychova L; Muller P; Kalathiya U; Lisowska MM; Kocikowski M; Parys M; Faktor J; Nekulova M; Nortcliffe C; Zatloukalova P; Ruetgen B; Fahraeus R; Ball KL; Argyle DJ; Vojtesek B; Hupp TR
    Biochem J; 2021 Jan; 478(1):99-120. PubMed ID: 33284343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of monoclonal antibody size variants containing extra light chains.
    Lu C; Liu D; Liu H; Motchnik P
    MAbs; 2013; 5(1):102-13. PubMed ID: 23255003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The critical role of arginine residues in the binding of human monoclonal antibodies to cardiolipin.
    Giles I; Lambrianides N; Latchman D; Chen P; Chukwuocha R; Isenberg D; Rahman A
    Arthritis Res Ther; 2005; 7(1):R47-56. PubMed ID: 15642142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Affinity profiling of monoclonal antibody and antibody-drug-conjugate preparations by coupled liquid chromatography-surface plasmon resonance biosensing.
    Lakayan D; Haselberg R; Gahoual R; Somsen GW; Kool J
    Anal Bioanal Chem; 2018 Dec; 410(30):7837-7848. PubMed ID: 30328504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heavy chain dimers stabilized by disulfide bonds are required to promote in vitro assembly of trastuzumab.
    Farràs M; Román R; Camps M; Miret J; Martínez Ó; Pujol X; Casablancas A; Cairó JJ
    BMC Mol Cell Biol; 2020 Jan; 21(1):2. PubMed ID: 31964343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Control of IgG LC:HC ratio in stably transfected CHO cells and study of the impact on expression, aggregation, glycosylation and conformational stability.
    Ho SC; Koh EY; van Beers M; Mueller M; Wan C; Teo G; Song Z; Tong YW; Bardor M; Yang Y
    J Biotechnol; 2013 Jun; 165(3-4):157-66. PubMed ID: 23583871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Domestication of suspension CHO cells and its application in the expression of anti-PSMA antibody].
    Wu J; Han D; Wei M; Zheng G; Jiao D; Xi W; Yang A; Qin W; Wen W
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Jan; 32(1):1-4. PubMed ID: 27358992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unraveling the effect of changes in conformation and compactness at the antibody V(L)-V(H) interface upon antigen binding.
    Pellequer JL; Chen Sw; Roberts VA; Tainer JA; Getzoff ED
    J Mol Recognit; 1999; 12(4):267-75. PubMed ID: 10440998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heavy and light chain contributions to antigen binding in an anti-digoxin chain recombinant antibody produced by transfection of cloned anti-digoxin antibody genes.
    Near RI; Ng SC; Mudgett-Hunter M; Hudson NW; Margolies MN; Seidman JG; Haber E; Jacobson MA
    Mol Immunol; 1990 Sep; 27(9):901-9. PubMed ID: 2120577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of antibody structural epitopes via random peptide library screening and next generation sequencing.
    Ibsen KN; Daugherty PS
    J Immunol Methods; 2017 Dec; 451():28-36. PubMed ID: 28827189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of internal ribosome entry site (IRES) and Furin-2A (F2A) for monoclonal antibody expression level and quality in CHO cells.
    Ho SC; Bardor M; Li B; Lee JJ; Song Z; Tong YW; Goh LT; Yang Y
    PLoS One; 2013; 8(5):e63247. PubMed ID: 23704898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Homogeneous antibody-drug conjugates: DAR 2 anti-HER2 obtained by conjugation on isolated light chain followed by mAb assembly.
    Farràs M; Miret J; Camps M; Román R; Martínez Ó; Pujol X; Erb S; Ehkirch A; Cianferani S; Casablancas A; Cairó JJ
    MAbs; 2020; 12(1):1702262. PubMed ID: 31876436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a Novel Inhibitory Chimeric Anti-HER2 Monoclonal Antibody.
    Amiri MM; Bahadori T; Soltantoyeh T; Hosseini-Ghatar R; Golsaz-Shirazi F; Jeddi-Tehrani M; Shokri F
    Iran J Immunol; 2019 Mar; 16(1):26-42. PubMed ID: 30864553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stability of ipilimumab in its original vial after opening allows its use for at least 4 weeks and facilitates pooling of residues.
    Bardo-Brouard P; Vieillard V; Shekarian T; Marabelle A; Astier A; Paul M
    Eur J Cancer; 2016 May; 58():8-16. PubMed ID: 26922168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.